Thursday, Dec 01, 2022

Pfizer shares tumble 7 per cent as company stops sale of Corex cough syrup

In view of the government ban on dertain combination drugs, the company has discontinued the manufacture and sale of Corex cough syrup with immediate effect.

pfizermnShares of pharmaceutical firm Pfizer on Monday slumped nearly 7 per cent as the company discontinued the manufacture and sale of popular cough syrup Corex with immediate effect.

The stock plunged 6.94 per cent to Rs 1,794 on BSE. At NSE, shares of the company tanked 6.85 per cent to Rs 1,796.

[related-post]

Pfizer has discontinued manufacture and sale of Corex cough syrup with immediate effect after the government banned fixed dose combination of Chlopheniramine Maleate+ Codeine Syrup.

Subscriber Only Stories
JK Cement’s SPSU Udaipur Launches ‘Golden Batch 2022’ In Collaboration Wi...Premium
Appendicitis in Children- A new lifestyle disorderPremium
Using evidence will create strong foundations for the future of education...Premium
Re-Defining The Tradition In Folk Art: An Art Educator’s PerspectivePremium

Read Also: Pfizer stops sale of cough syrup Corex after government ban 

“This is to inform you that the Government of India vide Notification… dated March 10, 2016… has prohibited the manufacture for sale and distribution of fixed dose combination of Chlopheniramine Maleate + Codeine Syrup with immediate effect,” Pfizer said in a BSE filing on Monday.

Read Also: Health Ministry bans 344 drugs, including Nimesulide 

In view of this, the company has discontinued the manufacture and sale of the drug with immediate effect, it said.

“The above prohibition is likely to have an adverse impact on the revenue and profitability of the company… Corex recorded sale of Rs 176 crore for the nine month period ended December 31, 2015,” the company said.

First published on: 14-03-2016 at 01:38:04 pm
Next Story

ICC World T20: Josh Hazlewood hat-trick may not be enough to make Australia XI

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
close